CRISPR

CRISPR3-nr3c1

ID
ZDB-CRISPR-201102-4
Name
CRISPR3-nr3c1
Previous Names
None
Target
Sequence
5' - CTGCCACATCGTCAGCTGG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
The PAM site was "TGG" at the 3' end.
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
sh543 nr3c1
Expression
Gene expression in Wild Types + CRISPR3-nr3c1
No data available
Phenotype
Phenotype resulting from CRISPR3-nr3c1
No data available
Phenotype of all Fish created by or utilizing CRISPR3-nr3c1
Phenotype Fish Conditions Figures
whole organism fkbp5 expression decreased amount, abnormal nr3c1sh543/sh543 standard conditions Fig. 3 with image from Marchi et al., 2020
adenohypophysis pomca expression increased amount, abnormal nr3c1sh543/sh543 standard conditions Fig. 3 with image from Marchi et al., 2020
adenohypophysis pomca expression increased amount, abnormal nr3c1sh543/sh543 chemical treatment by environment: betamethasone dipropionate Fig. 3 with image from Marchi et al., 2020
whole organism fkbp5 expression decreased amount, abnormal nr3c1sh543/sh543 chemical treatment by environment: betamethasone dipropionate Fig. 3 with image from Marchi et al., 2020
adenohypophysis pomca expression increased amount, abnormal nr3c1sh543/sh543; sh144Tg standard conditions Fig. 4 with image from Marchi et al., 2020
adenohypophysis pomca expression increased amount, abnormal vhlhu2117/hu2117; nr3c1sh543/sh543; sh144Tg standard conditions Fig. 4 with image from Marchi et al., 2020
whole organism vegfab expression increased amount, abnormal vhlhu2117/hu2117; nr3c1sh543/sh543; sh144Tg/sh144Tg chemical treatment by environment: betamethasone dipropionate Fig. 3 with image from Marchi et al., 2020
whole organism vegfab expression increased amount, abnormal vhlhu2117/hu2117; nr3c1sh543/sh543; sh144Tg/sh144Tg standard conditions Fig. 3 with image from Marchi et al., 2020
whole organism fkbp5 expression decreased amount, abnormal vhlhu2117/hu2117; nr3c1sh543/sh543; sh144Tg/sh144Tg chemical treatment by environment: betamethasone dipropionate Fig. 3 with image from Marchi et al., 2020
whole organism fkbp5 expression decreased amount, abnormal vhlhu2117/hu2117; nr3c1sh543/sh543; sh144Tg/sh144Tg standard conditions Fig. 3 with image from Marchi et al., 2020
whole organism egln3 expression increased amount, abnormal vhlhu2117/hu2117; nr3c1sh543/sh543; sh144Tg/sh144Tg chemical treatment by environment: betamethasone dipropionate Fig. 3 with image from Marchi et al., 2020
whole organism hypoxia-inducible factor-1alpha signaling pathway decreased efficacy, abnormal vhlhu2117/hu2117; nr3c1sh543/sh543; sh144Tg/sh144Tg standard conditions Fig. 6 with image from Marchi et al., 2020
whole organism egln3 expression increased amount, abnormal vhlhu2117/hu2117; nr3c1sh543/sh543; sh144Tg/sh144Tg standard conditions Fig. 3 with image from Marchi et al., 2020
whole organism hypoxia-inducible factor-1alpha signaling pathway decreased efficacy, abnormal vhlhu2117/hu2117; nr3c1sh543/sh543; sh144Tg + CRISPR3-nr3c2 + CRISPR4-nr3c2 + CRISPR5-nr3c2 + CRISPR6-nr3c2 standard conditions Fig. 6 with image from Marchi et al., 2020
Citations